enemy - Could very well be that the success that L

enemy - Could very well be that the success that LL has demonstrated as an immunomodulator has convinced the powers that be to investigate that path forward. Remember, back in the spring, the FDA and others (NIH) didn't think immunomodulation drug was relevant to Covid. This also suggests that now the FDA is seriously considering LL for an EUA. We will see next Tuesday.